Literature DB >> 24972722

What is the appropriate operative strategy for radiologically solid tumours in subcentimetre lung cancer patients?†.

Aritoshi Hattori1, Kenji Suzuki2, Takeshi Matsunaga1, Yoshikazu Miyasaka1, Kazuya Takamochi1, Shiaki Oh1.   

Abstract

OBJECTIVES: Solid lung cancers, even subcentimetre lesions, are considered to be invasive pathologically. However, the clinicopathological features and appropriate operative strategies in patients with these small lesions are still controversial, especially for those with a radiologically solid appearance.
METHODS: Between 2004 and 2011, 135 patients underwent pulmonary resection for subcentimetre lung cancer with clinical-N0 (c-N0) status. The findings of preoperative thin-section computed tomography (CT) were reviewed, and subcentimetre lung cancer was divided into three groups: pure ground-glass nodule, part-solid and pure-solid lesions.
RESULTS: Among the 135 subcentimetre lung cancer patients with c-N0 status, 71 showed a solid appearance on thin-section CT scan. Furthermore, pathological nodal examinations were performed in 49 patients, and nodal involvement was found pathologically in 6 (12.2%) patients. All of them had pure-solid tumours (P = 0.0010). Among the patients with solid subcentimetre lung cancers, the maximum standardized uptake value (SUVmax) was the only significant predictor of nodal involvement by a multivariate analysis (P = 0.0205). With regard to the surgical outcomes, the overall 5-year survival and disease-free survival rates were 100 and 97.8% for part-solid lesions, and 87.3 and 74.8% for pure-solid lesions, respectively. Moreover, there was a significant difference in disease-free survival between a high SUVmax group (60.0%) and a low SUVmax group (94.9%) (P = 0.0013).
CONCLUSIONS: There might be a possibility of lymph node metastasis despite subcentimetre lung cancer, especially for radiological pure-solid nodules that show a high SUVmax. If limited surgery is indicated for solid subcentimetre lung cancer, a thorough intraoperative evaluation of lymph nodes is needed to prevent loco-regional failure.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Lymph node metastasis; Prognosis; Solid appearance; Sub centimetre

Mesh:

Year:  2014        PMID: 24972722     DOI: 10.1093/ejcts/ezu250

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

1.  The oncological outcomes of segmentectomy in clinical-T1b lung adenocarcinoma with a solid-dominant appearance on thin-section computed tomography.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-10-15       Impact factor: 2.549

2.  Oncological outcomes of sublobar resection for clinical-stage IA high-risk non-small cell lung cancer patients with a radiologically solid appearance on computed tomography.

Authors:  Aritoshi Hattori; Kazuya Takamochi; Takeshi Matsunaga; Shiaki Oh; Kenji Suzuki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-01

Review 3.  Controversies on lung cancers manifesting as part-solid nodules.

Authors:  Rowena Yip; Kunwei Li; Li Liu; Dongming Xu; Kathleen Tam; David F Yankelevitz; Emanuela Taioli; Betsy Becker; Claudia I Henschke
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

4.  Procedure-specific prognostic impact of micropapillary subtype may guide resection strategy in small-sized lung adenocarcinomas: a multicenter study.

Authors:  Hang Su; Huikang Xie; Chenyang Dai; Shengnan Zhao; Dong Xie; Yunlang She; Yijiu Ren; Lei Zhang; Ziwen Fan; Donglai Chen; Feng Jiang; Jinshi Liu; Quan Zhu; Jie Yao; Honggang Ke; Lei Zhang; Chunyan Wu; Gening Jiang; Chang Chen
Journal:  Ther Adv Med Oncol       Date:  2020-07-03       Impact factor: 8.168

5.  The impact on the prognosis of unsuspected N2 disease in non-small-cell lung cancer: indications for thorough mediastinal staging in the modern era.

Authors:  Ryosuke Tachi; Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2016-07-21       Impact factor: 2.549

Review 6.  [Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer].

Authors:  Bo Liu; Fengxia Ding; Shuangqiang Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-06

7.  Less is more in solid-dominant lung cancer? Sublobar resection versus lobectomy for solid-dominant stage IA non-small-cell lung cancer: A meta-analysis study.

Authors:  Juntang Guo; Yang Liu; Xiaodong Tian; Zhipeng Ren; Jixing Lin; Bailin Wang; Chaoyang Liang
Journal:  Mol Clin Oncol       Date:  2019-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.